The Fred Hutchinson Cancer Research Center (FHCRC) is an independent, non-profit research institution located in Seattle, Washington, United States. Established in 1972, it was founded by Dr. William Hutchison in memory of his brother, Fred Hutchinson, a professional baseball player who died of lung cancer. The FHCRC is internationally recognized for its pioneering work in cancer research, prevention, treatment, and the development of innovative therapies. Its mission is to eliminate cancer and related diseases as causes of human suffering and death. The center conducts groundbreaking research in various fields, including basic science, population sciences, clinical research, and translational medicine. The FHCRC operates under a unique collaborative model, bringing together teams of scientists and clinicians from various disciplines to work together in a multidisciplinary approach. This collaborative environment fosters cross-pollination of ideas and accelerates the translation of scientific discoveries into clinical applications. With state-of-the-art facilities and a dedicated team of over 3,000 employees, including world-renowned researchers and clinicians, the FHCRC is at the forefront of scientific discovery and innovation in cancer research. It has made significant contributions to the understanding of cancer biology, the development of targeted therapies, immunotherapy, and precision medicine. In addition to its research endeavors, the FHCRC is committed to training the next generation of scientists and physicians through its graduate and postdoctoral programs. It also actively collaborates with other research institutions, industry partners, and government agencies to bring its research findings to patients and communities around the world. Overall, the Fred Hutchinson Cancer Research Center has established itself as a leader in the fight against cancer, making significant strides in advancing our knowledge and improving patient outcomes through its cutting-edge research and collaborative efforts.